.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
McKinsey
Johnson and Johnson
Baxter
Deloitte
Cantor Fitzgerald
McKesson
Farmers Insurance
Chubb
Mallinckrodt

Generated: July 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 073609

« Back to Dashboard
NDA 073609 describes PINDOLOL, which is a drug marketed by Idt Australia Ltd, Mylan Pharms Inc, Nostrum Labs Inc, G And W Labs Inc, Purepac Pharm, Watson Labs, Sun Pharm Inds, and Nostrum Labs, and is included in thirteen NDAs. It is available from five suppliers. Additional details are available on the PINDOLOL profile page.

The generic ingredient in PINDOLOL is pindolol. There are eleven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the pindolol profile page.

Summary for NDA: 073609

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 073609

Mechanism of ActionAdrenergic beta-Antagonists

Suppliers and Packaging for NDA: 073609

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PINDOLOL
pindolol
TABLET;ORAL 073609 ANDA ANI Pharmaceuticals, Inc. 62559-561 62559-561-01 100 TABLET in 1 BOTTLE (62559-561-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Mar 29, 1993TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
US Department of Justice
Express Scripts
Deloitte
Accenture
AstraZeneca
Harvard Business School
Julphar
UBS
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot